Matches in Wikidata for { <http://www.wikidata.org/entity/Q66027406> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q66027406 description "clinical trial" @default.
- Q66027406 description "ensayu clínicu" @default.
- Q66027406 description "klinisch onderzoek" @default.
- Q66027406 description "клінічне випробування" @default.
- Q66027406 name "The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer" @default.
- Q66027406 name "The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer" @default.
- Q66027406 type Item @default.
- Q66027406 label "The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer" @default.
- Q66027406 label "The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer" @default.
- Q66027406 prefLabel "The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer" @default.
- Q66027406 prefLabel "The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer" @default.
- Q66027406 P1132 Q66027406-C54B67EF-E8F3-40E8-94A7-DF6E12F30CED @default.
- Q66027406 P1476 Q66027406-62E3B995-8EAB-49C7-BA91-796B68A3DDD5 @default.
- Q66027406 P17 Q66027406-0C6A6744-FAF2-498D-B3CA-ACF0F9D2768D @default.
- Q66027406 P17 Q66027406-63C72F0E-DAB4-4C09-BF66-B16CD64A32D1 @default.
- Q66027406 P17 Q66027406-9A7CB6A2-42E9-4E5B-93A9-54423A808C5B @default.
- Q66027406 P17 Q66027406-9DFA6F42-E4C5-4EE9-AF85-CE24D895E291 @default.
- Q66027406 P17 Q66027406-9FB12038-BB37-4CF6-96FF-739E67AE739B @default.
- Q66027406 P17 Q66027406-A2FAB864-286A-4D34-8371-498A1BA0D21F @default.
- Q66027406 P17 Q66027406-CE101E42-FDA2-43C8-82D8-79E0993AA16F @default.
- Q66027406 P17 Q66027406-F86383C0-2976-4633-BF48-BC88F9FE218F @default.
- Q66027406 P2899 Q66027406-CFAA98D1-14D4-43AA-802C-E5C3F4A2EEB8 @default.
- Q66027406 P3098 Q66027406-A07235AB-5C89-4B54-8E77-39CF49E8BF98 @default.
- Q66027406 P31 Q66027406-631635CF-5072-440A-A1F9-7FF93774E927 @default.
- Q66027406 P580 Q66027406-42A423D8-6E5A-48A1-BB59-7225F5A3E46D @default.
- Q66027406 P582 Q66027406-5886D7E3-BEF6-415B-AD1F-73E6EE8C28DD @default.
- Q66027406 P6099 Q66027406-1415C2B4-F2B9-4908-B309-BC241505693D @default.
- Q66027406 P6153 Q66027406-085649D4-8311-4FF5-BD2B-503B16781A93 @default.
- Q66027406 P8363 Q66027406-AEF8FAC9-A4ED-438D-9462-C2C5B2C822AD @default.
- Q66027406 P859 Q66027406-2F624617-074F-4CA1-81CB-582935CD8C51 @default.
- Q66027406 P1132 "+527" @default.
- Q66027406 P1476 "The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer" @default.
- Q66027406 P17 Q142 @default.
- Q66027406 P17 Q258 @default.
- Q66027406 P17 Q29 @default.
- Q66027406 P17 Q31 @default.
- Q66027406 P17 Q38 @default.
- Q66027406 P17 Q414 @default.
- Q66027406 P17 Q55 @default.
- Q66027406 P17 Q851 @default.
- Q66027406 P2899 "+18" @default.
- Q66027406 P3098 "NCT00171314" @default.
- Q66027406 P31 Q30612 @default.
- Q66027406 P580 "2004-03-01T00:00:00Z" @default.
- Q66027406 P582 "2010-11-01T00:00:00Z" @default.
- Q66027406 P6099 Q42824827 @default.
- Q66027406 P6153 Q507154 @default.
- Q66027406 P8363 Q78089383 @default.
- Q66027406 P859 Q507154 @default.